# Dendritic Cell Based Therapy for Breast Cancer Patients

> **NCT00935558** · PHASE2 · WITHDRAWN · sponsor: **Inge Marie Svane**

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** DC vaccine
- **DRUG:** aromatase inhibitor

## Key facts

- **NCT ID:** NCT00935558
- **Lead sponsor:** Inge Marie Svane
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-07
- **Primary completion:** 2012-05
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no patients enrolled
- **Last updated:** 2012-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00935558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00935558, "Dendritic Cell Based Therapy for Breast Cancer Patients". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00935558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*